Ascendance Biotechnology
Medford, US · Founded 2015 · Delaware corporation
Founders & leadership
JK
John K McGeehanExecutive
VR
Vincent R, Jr ZurawskiNamed on SEC filing
JJ
Jeffrey JanusNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$880K disclosed across 2 rounds · 2015–2016
▶$230KraisedMay 2016 · 10 investors · BiotechnologyRule 506(b)
▶$230KraisedMay 2016 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael D. WestDirector
- Alfred D. KingsleyDirector
- John K. McGeehanExecutive Officer, Promoter
- Robert G. WilkensDirector
- Morton CollinsDirector
- Vincent R., Jr. ZurawskiExecutive Officer, Director, Promoter
- Jeffrey D. JanusExecutive Officer, Director, Promoter
- Martin J. JoyceExecutive Officer
- Offering amount
- $300K
- Amount sold
- $230K
- First sale
- May 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$650KraisedDec 2015 · 6 investors · BiotechnologyRule 506(b)
▶$650KraisedDec 2015 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Vincent R, Jr ZurawskiExecutive Officer, Director, Promoter
- Jeffrey JanusExecutive Officer, Director, Promoter
- John K McGeehanExecutive Officer, Promoter
- Offering amount
- $750K
- Amount sold
- $650K
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Ascendance Biotechnology raised?
- Ascendance Biotechnology has disclosed $880K raised across 2 rounds.
- Where is Ascendance Biotechnology headquartered?
- Ascendance Biotechnology is headquartered in Medford, US.